Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

Andrei R. Shustov, MD, Bertrand Coiffier, MD, PhD, Steven M. Horwitz, MD, Lubomir Sokol, MD, Ph.D, Barbara Pro, MD, Tina Nielsen, MD, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Robin Eisch, RN, Leslie Popplewell, MD, Miles Prince, MD, FRACP, FRCPA, Steven L. Allen, M.D., Richard Piekarz, MD, PhD, Susan E. Bates, MD

Blood (2013) 122 (21): 4385.

https://doi.org/10.1182/blood.V122.21.4385.4385

Published: 2013

Journal Articles

Concomitant, T-Independent TLR9-Mediated and BCR-Mediated Activation Provides Signals For Optimal Telomerase Induction In Chronic Lymphocytic Leukemia Cells Regardless Of IGHV Mutation Status

Rajendra N Damle, PhD, Sonal Temburni, MS, Ryon M. Andersen, B.A., Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 4142.

https://doi.org/10.1182/blood.V122.21.4142.4142

Published: 2013

Journal Articles

Lenalidomide Promotes The Expansion Of CD8 T Cells With An Effector Memory Phenotype In a Murine Xenograft Model Of Chronic Lymphocytic Leukemia

Rita Simone, PhD, Sonia Marsilio, PhD, Piers E.M. Patten, MD, PhD, Gerardo Ferrer, PhD, Shih-Shih Chen, Ph.D., Xiao J. Yan, MD, PhD, Stefano Vergani, Msc, Andrea Nicola Mazzarello, PhD, Jacqueline C. Barrientos, MD, Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 119.

https://doi.org/10.1182/blood.V122.21.119.119

Published: 2013

Journal Articles

TLR-9 and B-Cell Antigen Receptor Triggering of Primary B Cells From Mantle Cell Lymphoma Induce Cell Proliferation and Telomerase Activity,

Sonal Temburni, MS, Ryon M. Andersen, B.A., Steven L. Allen, M.D., Jaqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D., Rajendra N Damle, PhD

Blood (2011) 118 (21): 3690.

https://doi.org/10.1182/blood.V118.21.3690.3690

Published: 2011

Journal Articles

Co-Culture of CLL Cells with MEACs (Myosin Heavy Chain IIA Exposed Apoptotic Cells) Promotes Viability of Leukemic Clones

Charles C. Chu, Ph.D., Xiaoxuan Cui, M.D., Ph.D., Rosa Catera, Ph.D., Lu Zhang, M.S., Amanda R. Magli, B.S.E., Xiao-Jie Yan, M.D., Ph.D., Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 624.

https://doi.org/10.1182/blood.V118.21.624.624

Published: 2011

Journal Articles

Longitudinal Analyses of CXCR4 dim CD5 br CD19 + Fractions of Chronic Lymphocytic Leukemia Clones Reveal Features Consistent with a Source of Clonal Heterogeneity

Rajendra N Damle, PhD, Carlo Calissano, MD, Sonal Temburni, MS, Ryon M. Andersen, B.A., Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 804.

https://doi.org/10.1182/blood.V118.21.804.804

Published: 2011

Journal Articles

Engraftment of CLL-Derived T Cells in NSG Mice Is Feasible, Can Support CLL Cell Proliferation, and Eliminates the Need for Third Party Antigen Presenting Cells

Piers EM Patten, BSc, MBBCh, PhD, Shih-Shih Chen, Ph.D., Davide Bagnara, Ph.D., Rita Simone, PhD, Sonia Marsilio, PhD, Timothy Tong, Jaqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Kanti R Rai, MD, Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 975.

https://doi.org/10.1182/blood.V118.21.975.975

Published: 2011

Journal Articles

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

Xiao J. Yan, MD, PhD, Daniel Kalenscher, Erin Boyle, Sophia Yancopoulos, PhD, Rajendra N Damle, PhD, Aarti Damle, Houman Khalili, Annette Lee, PhD, Wentian Li, Ph.D., Igor Dozmorov, MD, PhD, Matthew Kaufman, M.D., Peter Gregersen, MD, Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 2833.

https://doi.org/10.1182/blood.V118.21.2833.2833

Published: 2011

Journal Articles

Successful Therapy of Cold Agglutinin Disease Utilizing Rituximab

Michelle Cholankeril, MD, Thomas P. Bradley, MD, Craig Devoe, MD, Cristina Maria Ghiuzeli, MD, Jonathan E. Kolitz, MD, Steven L. Allen, M.D.

Blood (2011) 118 (21): 5271.

https://doi.org/10.1182/blood.V118.21.5271.5271

Published: 2011

Journal Articles

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 1774.

https://doi.org/10.1182/blood.V118.21.1774.1774

Published: 2011

Journal Articles

Pregnancy-Induced Thrombocytopenia in Pseudo-Von Willebrand Disease

Simi George, MD, Laura L. Donahue, MD, Dorothy M (Adcock) Funk, MD, Steven L. Allen, M.D.

Blood (2011) 118 (21): 4658.

https://doi.org/10.1182/blood.V118.21.4658.4658

Published: 2011

Journal Articles

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Shih-Shih Chen, Ph.D., Matthew Kaufman, M.D., Angelica Caramanica, Rajendra N Damle, Ph.D., Peter Garofalo, Patricia Ly, Dale Janson, Steven L. Allen, M.D., Jonathan Kolitz, M.D., Linda Quill, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2010) 116 (21): 1392.

https://doi.org/10.1182/blood.V116.21.1392.1392

Published: 2010

Journal Articles

Elevated Binding of Chronic Lymphocytic Leukemia Antibody to a Subset of Apoptotic Cells with Exposed Non-Muscle Myosin Heavy Chain IIA Correlates with Poor Patient Outcome.

Charles C. Chu, Ph.D., Rosa Catera, Ph.D., Lu Zhang, M.A., Briana M. Agagnina, Sebastien Didier, M.S., Jonathan E. Kolitz, M.D., Steven L. Allen, M.D., Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2009) 114 (22): 799.

https://doi.org/10.1182/blood.V114.22.799.799

Published: 2009

Journal Articles

p53 and COX-2 Inhibitors Control the Replication and Viability of Non-Transformed and CLL B Lymphocytes

Patricia Mongini, Ph.D., Matthew Kaufman, M.D., Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Joshua Trott, Kanti Rai, M.D., Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3146.

https://doi.org/10.1182/blood.V112.11.3146.3146

Published: 2008

Journal Articles

Expression Levels of a Single Gene, Lymphoid Enhancer Binding Factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies.

Brian A. McCarthy, PhD, Mike Tipping, Ph.D., Xue Ping Wang, Ph.D., Fiona Bennet, Ph.D., Wentian Li, Ph.D., Martin Lesser, Ph.D., Santanu Paul, Ph.D., Erin Boyle, B.S., Carol Moreno, Ph.D., Rosa Catera, Ph.D., Bradley T. Messmer, Ph.D., Steven L. Allen, M.D., Andrew C. Rawstron, M.D., Kanti R. Rai, M.D, Nicholas Chiorazzi, M.D.

Blood (2007) 110 (11): 1113.

https://doi.org/10.1182/blood.V110.11.1113.1113

Published: 2007

Journal Articles

B-CLL Antibodies Encoded by Stereotypic V H 1-69 , D3-16 , and J H 3 Rearrangements Immunoprecipitate Non-Muscle Myosin Heavy Chain IIA.

Charles C. Chu, PhD, Lu Zhang, Katerina Hatzi, Rosa Catera, Ph.D., Steven L. Allen, M.D., Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2007) 110 (11): 739.

https://doi.org/10.1182/blood.V110.11.739.739

Published: 2007

Journal Articles

B-CLL Antibodies Comprised of Stereotypic V H 1-69, D3-16, and J H 3 Rearrangements Immunoprecipitate Cellular Protein(s).

Charles C. Chu, PhD, Xiao Bo Wang, M.D., Katerina Hatzi, Rosa Catera, Ph.D., Eric Meffre, Ph.D., Maxime Herve, Steven L. Allen, M.D., Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2006) 108 (11): 2816.

https://doi.org/10.1182/blood.V108.11.2816.2816

Published: 2006

Journal Articles

Nonpuerperal Ovarian Vein Thrombosis: A Report of Seven Cases.

Debra Ferman, M.D., Thomas P. Bradley, M.D., Robin Warshawsky, M.D., Steven L. Allen, M.D.

Blood (2004) 104 (11): 4038.

https://doi.org/10.1182/blood.V104.11.4038.4038

Published: 2004

NARROW

Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

Concomitant, T-Independent TLR9-Mediated and BCR-Mediated Activation Provides Signals For Optimal Telomerase Induction In Chronic Lymphocytic Leukemia Cells Regardless Of IGHV Mutation Status

Lenalidomide Promotes The Expansion Of CD8 T Cells With An Effector Memory Phenotype In a Murine Xenograft Model Of Chronic Lymphocytic Leukemia

TLR-9 and B-Cell Antigen Receptor Triggering of Primary B Cells From Mantle Cell Lymphoma Induce Cell Proliferation and Telomerase Activity,

Co-Culture of CLL Cells with MEACs (Myosin Heavy Chain IIA Exposed Apoptotic Cells) Promotes Viability of Leukemic Clones

Longitudinal Analyses of CXCR4 dim CD5 br CD19 + Fractions of Chronic Lymphocytic Leukemia Clones Reveal Features Consistent with a Source of Clonal Heterogeneity

Engraftment of CLL-Derived T Cells in NSG Mice Is Feasible, Can Support CLL Cell Proliferation, and Eliminates the Need for Third Party Antigen Presenting Cells

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

Successful Therapy of Cold Agglutinin Disease Utilizing Rituximab

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Pregnancy-Induced Thrombocytopenia in Pseudo-Von Willebrand Disease

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Elevated Binding of Chronic Lymphocytic Leukemia Antibody to a Subset of Apoptotic Cells with Exposed Non-Muscle Myosin Heavy Chain IIA Correlates with Poor Patient Outcome.

p53 and COX-2 Inhibitors Control the Replication and Viability of Non-Transformed and CLL B Lymphocytes

Expression Levels of a Single Gene, Lymphoid Enhancer Binding Factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies.

B-CLL Antibodies Encoded by Stereotypic V H 1-69 , D3-16 , and J H 3 Rearrangements Immunoprecipitate Non-Muscle Myosin Heavy Chain IIA.

B-CLL Antibodies Comprised of Stereotypic V H 1-69, D3-16, and J H 3 Rearrangements Immunoprecipitate Cellular Protein(s).

Nonpuerperal Ovarian Vein Thrombosis: A Report of Seven Cases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only